Overview * Boston Scientific ( BSX ) Q3 revenue grows 20.3%, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reaching $0.75 * Company discontinues sales of ACURATE valve systems globally Outlook * Boston Scientific ( BSX ) estimates full-year 2025 net sales growth of ~20% reported, 15.5% organic * Company expects Q4 2025 net sales growth of 14.5%-16.5%...

Oct 22 (Reuters) - Medical equipment maker Thermo Fisher beat analysts' estimates for third-quarter revenue and profit on Wednesday, owing to strong demand for its tools and technologies that are used to develop therapies. Contract research firms such as Thermo Fisher are seeing renewed demand as pharmaceutical companies ramp up drug development and manufacturing, while benefiting from easing trade tensions....

06:44 AM EDT, 10/22/2025 (MT Newswires) -- China's Ministry of Commerce on Wednesday released questionnaires requiring some US semiconductor firms for information on sales activities in China, including cost and profit comparisons between their operations in the US and China. The forms also ask for names of Chinese customers, transaction details, and raw material supplier information as part of an...

Overview * Wabtec Q3 sales rise 8.4% to $2.89 bln, beating analyst expectations * Adjusted EPS for Q3 increases 16% to $2.32, surpassing analyst estimates * Company raises and tightens 2025 adjusted EPS guidance Outlook * Wabtec expects 2025 adjusted EPS guidance to $8.85-$9.05 * Company expects 2025 revenue between $10.925 bln and $11.225 bln * Wabtec anticipates operating cash...